Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities is a research paper published in Oncology Reports (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA080127
NCI NIH HHS
Grant: P30 CA015083
NIA NIH HHS
Grant: R01 AG034676
NCI NIH HHS
Grant: R01 CA084354
NIA NIH HHS
Grant: R01 AG052425
NCI NIH HHS
Grant: R03 CA077118
National Institutes of Health
Grant: 5R03CA077118-02
DEVELOPMENT OF LUNG CANCER EPIDEMIOLOGY RESEARCH
National Institutes of Health
Grant: 5R01CA084354-10
Genetic Determinants of Lung Cancer Survival
National Institutes of Health
Grant: 5R01AG034676-52
Multimorbidity and Aging: Rochester Epidemiology Project
National Institutes of Health
Grant: 5R01CA080127-04
ALPHA 1 AD CARRIERS AND LUNG CANCER RISK
National Institutes of Health
Grant: 5R01AG052425-05
Multiple Chronic Conditions and Aging
FWCI
2.88
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals